DelveInsight launched a new report on Aspergillosis Epidemiology Forecast, 2030.
Aspergillosis is an infection caused by Aspergillus, a common mold (a type of fungus) that lives indoors and outdoors. Most people breathe in Aspergillus spores every day without getting sick. However, people with weakened immune systems or lung diseases are at a higher risk of developing health problems due to Aspergillus.
DelveInsight’s ‘Aspergillosis Epidemiology Forecast to 2030‘ report delivers an in-depth understanding of the disease, historical and forecasted Aspergillosis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Some of the key highlights from the Aspergillosis Epidemiology Report:
The total prevalent population of three major subtypes. i.e., ABPA, IA, and CPA were around 546,697 in the United States (in 2018). The diagnosis rate is highest for IA (i.e., more severe compared to ABPA and CPA), followed by expected similar rates for ABPA and CPA.
As per DelveInsight’s analysis, the diagnosed and treated cases of ABPA, IA, and CPA were found to be 1,124,997, 37,528, and 23,831 respectively in 2018 in the 7MM.
Visit for more @ Aspergillosis Epidemiology Insights
Scope of the Aspergillosis Epidemiology report:
The Aspergillosis report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis, and treatment patterns
The Aspergillosis Epidemiology Report and Model provide an overview of the risk factors and global trends of Aspergillosis in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan)
The report provides insight into the historical and forecasted patient pool of Aspergillosis in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
The report helps to recognize the growth opportunities in the 7MM concerning the patient population
The report assesses the disease risk and burden and highlights the unmet needs of Aspergillosis
The report provides the segmentation of the Aspergillosis epidemiology
Table of Contents:
1. Key Insights
2. Executive Summary of Aspergillosis
3. Aspergillosis Epidemiology Overview at a Glance
4. Aspergillosis: Disease Background and Overview
5. Epidemiology and Patient Population
6. Case Reports
7. Country Wise-Epidemiology of Aspergillosis
9. DelveInsight Capabilities
11. About DelveInsight
DelveInsight’s ‘Aspergillosis-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
“Aspergillosis Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Aspergillosis market. A detailed picture of the Aspergillosis pipeline landscape is provided, which includes the disease overview and Aspergillosis treatment guidelines.
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Address:304 S. Jones Blvd #2432
City: Las Vegas
Country: United States